ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

37,321Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 1448

$3.8M Total Retail Price of All Prescriptions

Rank: 2 out of 1448

1,370 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 35,669 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

59% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$102 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
CRESTOR 1,908 1,823 10 1 17
ISOSORBIDE MONONITRATE ER 1,751 1,671 10 2 16
DIOVAN 1,557 1,503 10 3 15
METOPROLOL SUCCINATE 1,394 1,259 4 6
PLAVIX 1,192 1,158 10 5 14
RANEXA 1,126 1,080 10 6 37
CLOPIDOGREL 1,105 1,062 7 10
TRILIPIX 933 875 10 8 86
BYSTOLIC 929 893 9 32
AMLODIPINE BESYLATE 893 846 10 2
ATORVASTATIN CALCIUM 813 777 11 4
DIGOXIN 758 725 12 13
SIMVASTATIN 727 680 13 3
LOVAZA 716 652 14 39
NEXIUM 688 657 15 49
ISOSORBIDE DINITRATE 674 643 10 16 63
FUROSEMIDE 631 611 17 7
AMIODARONE HCL 601 585 10 18 22
SOTALOL 560 525 10 19 40
BENICAR 526 522 20 50
EFFIENT 519 482 10 21 69
ZOLPIDEM TARTRATE 485 479 22 34
WELCHOL 459 418 10 23 103
CELEBREX 443 437 24 77
SPIRIVA 428 422 25 97
TAMSULOSIN HCL 367 366 26 46
LOSARTAN POTASSIUM 348 339 27 11
LIDODERM 332 321 28 81
CARVEDILOL 325 302 29 1
DIOVAN HCT 313 309 30 29
WARFARIN SODIUM 288 263 31 8
ZETIA 287 272 32 28
ALENDRONATE SODIUM 268 268 33 41
ACTONEL 264 261 34 117
HYDRALAZINE HCL 261 259 35 44
NITROSTAT 259 241 36 31
CILOSTAZOL 253 251 37 95
SINGULAIR 250 246 38 91
EXFORGE 240 230 39 80
AZOR 232 232 40 125
LYRICA 224 218 41 159
MELOXICAM 222 209 42 73
PAROXETINE HCL 220 213 43 121
FAMOTIDINE 211 203 44 60
CREON 207 200 45 168
VYTORIN 205 192 46 71
LEVOTHYROXINE SODIUM 202 201 47 21
URSODIOL 199 194 48 259
OMEPRAZOLE 198 183 49 23
POTASSIUM CHLORIDE 198 196 49 19
FENOFIBRATE 196 184 51 54
GABAPENTIN 189 183 52 51
MULTAQ 180 179 53 57
DONEPEZIL HCL 180 180 53 68
METFORMIN HCL 176 169 55 25
PANTOPRAZOLE SODIUM 170 146 56 42
AVODART 169 169 57 120
LIPITOR 167 162 58 30
JANUVIA 162 158 59 64
ADVAIR DISKUS 146 145 60 74
CYCLOBENZAPRINE HCL 144 142 R 61 214
NAMENDA 139 139 62 93
HYDROCHLOROTHIAZIDE 132 131 63 18
ATELVIA 131 123 64 157
NIASPAN 131 127 64 47
DEXILANT 129 125 66 87
DILTIAZEM 24HR CD 124 124 67 61
MONTELUKAST SODIUM 123 120 68 135
MEXILETINE HCL 122 122 10 69 311
BENICAR HCT 122 113 69 84
XARELTO 118 116 71 58
ADVAIR HFA 116 116 72 245
PRADAXA 114 114 73 27
MEGESTROL ACETATE 110 110 R 74 126
SPIRONOLACTONE 109 95 75 24
VOLTAREN 106 104 76 107
LISINOPRIL 103 78 77 5
IBANDRONATE SODIUM 102 102 78 148
FLUDROCORTISONE ACETATE 101 98 79 322
COUMADIN 97 97 80 101
TRICOR 97 97 80 94
FINASTERIDE 95 95 82 141
ZENPEP 93 93 83 331
COMBIVENT 91 78 84 147
LABETALOL HCL 89 78 85 100
LEVOFLOXACIN 89 81 85 131
LANSOPRAZOLE 87 85 87 165
PRANDIN 84 83 88 225
BRILINTA 82 77 10 89 222
GLIPIZIDE 82 78 89 75
NASONEX 79 75 91 155
LUNESTA 79 70 91 218
TEKTURNA 77 77 93 106
KLOR-CON 8 75 74 94 70
NATEGLINIDE 75 74 94 160
GLYBURIDE-METFORMIN HCL 73 69 R 96 132
TERAZOSIN HCL 72 72 97 116
BENAZEPRIL HCL 70 65 98 26
ANTARA 70 60 98 277
MICARDIS 70 70 98 143
TRIBENZOR 70 55 98 170
ATENOLOL 69 52 102 12
GLIMEPIRIDE 68 60 103 66
JANUMET 65 65 104 119
BONIVA 64 63 105 167
MECLIZINE HCL 63 60 106 108
CLONIDINE HCL 62 54 107 45
LOSARTAN-HYDROCHLOROTHIAZIDE 62 57 107 38
ALLOPURINOL 59 57 109 43
TRAMADOL HCL 58 52 110 56
ULORIC 57 54 111 146
DILTIAZEM 24HR ER 55 54 112 52
ENALAPRIL MALEATE 52 40 113 48
DILTIAZEM HCL 52 52 113 145
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.